tES Modalities for the Treatment of ADHD
Transcranial Electrical Stimulation Modalities for the Treatment of Clinical Symptoms and Cognitive Deficits in Attention-deficit Hyperactivity Disorder Disorder
1 other identifier
interventional
45
1 country
1
Brief Summary
This project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2025
CompletedFirst Submitted
Initial submission to the registry
April 30, 2025
CompletedFirst Posted
Study publicly available on registry
May 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedMay 15, 2025
May 1, 2025
11 months
April 30, 2025
May 8, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
ADHD symptoms- Clinical rating scale
ADHD symptoms will be assessed using a DSM-based structured interview. This approach involves a systematic, standardized method to evaluate the presence and severity of ADHD symptoms based on the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM), likely the DSM-5, which is widely used for diagnosing ADHD.
Baseline, week 2, up to 1 month after the intervention
Secondary Outcomes (3)
Executive function- Performance accuracy and reaction time
Baseline, week 2, up to 1 month after the intervention
electroencephalogram (EEG) power
Baseline, week 2
electroencephalogram (EEG) functional connectivity
Baseline, week 2
Study Arms (3)
active tDCS group
ACTIVE COMPARATORThis group receives Transcranial Direct Current Stimulation (tDCS). tDCS delivers a constant, low-intensity direct current (typically 1-2 mA) through electrodes placed on the scalp. The anode (positive electrode) increases cortical excitability by depolarizing neurons, while the cathode (negative electrode) decreases excitability by hyperpolarizing neurons.
active tACS group
ACTIVE COMPARATORThis group receives Transcranial Alternating Current Stimulation (tACS). tACS applies an oscillating current at specific frequencies (e.g., 1-100 Hz) to entrain or synchronize neural oscillations. By aligning the stimulation frequency with endogenous brain rhythms (e.g., theta or gamma bands), tACS can modulate network dynamics, potentially normalizing aberrant oscillatory patterns associated with disorders like ADHD.
sham group
PLACEBO COMPARATORThis group receives sham stimulation. The stimulation duration is for 1 minuetand the device will be turned off after the stimulation
Interventions
Transcranial electrical stimulation (tES) is a non-invasive neuromodulation technique that applies low-intensity electrical currents to the scalp to modulate brain activity. It targets specific brain regions to influence neuronal excitability, connectivity, and plasticity, offering potential therapeutic benefits for neurological and psychiatric conditions. tES is portable, cost-effective, and generally well-tolerated, with minimal side effects such as mild tingling or itching at the stimulation site.
Eligibility Criteria
You may qualify if:
- Diagnosis of ADHD by a licensed psychiatrist and a behavioral checklist
- being 7-18 years old
- providing written informed consent signed by parents
You may not qualify if:
- comorbidity with other neurodevelopmental disorders
- Comorbidity with other neurological disorders
- previous history of neurosurgery
- Presence of any ferromagnetic metal in the head
- implanted medical devices in the head or neck region
- history of non-controlled epilepsy with seizures in the last year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Research in Fundamental Sciences
Tehran, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 30, 2025
First Posted
May 15, 2025
Study Start
March 30, 2025
Primary Completion
March 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
May 15, 2025
Record last verified: 2025-05